- Arthrosi Therapeutics: Arthrosi Therapeutics Completes Enrollment in Pivotal Phase 3 REDUCE 2 Trial of AR882 for the Treatment of Gout and Tophaceous Gout
- Pharmacy Times: Pharmacists Can Stay Aware of the Evolving Landscape of Gout Treatment to Address Unmet Needs
- Medical Life Sciences News: Can the carnivore diet trigger kidney stones? Case study raises red flags
- HCPLive: Pegloticase Does Not Increase Risk of CV/TE Events in People With Gout
- Clinical Pain Advisor: Gout Flares Often Underreported in US Adults With Gout
- Fierce Pharma: Takeda bids adieu to Uloric after gout med’s gradual fade from glory
- Healio: Many US rheumatologists fail to follow ACR gout guidelines for urate lowering drug dosage
- Physician’s Weekly: Which Patients Are Most Likely to Underreport Gout Flares?
- Medscape: Colchicine Guards Heart While Fighting Gout Flares
- Medscape: Lowering Urate May Protect Kidneys in Gout Patients with CKD